J.P. Morgan 36th Annual Healthcare Conference

Published on 04/12/2017

January 8-11, 2018

San Francisco, CA, California

“ENYO Pharma team will be at San Francisco during the J.P. Morgan conference, hosting the largest and most informative healthcare investment symposium in the industry. In 2018, more than 400 companies are expected, both public and private, to deliver presentations to more than 8,000 attendees.” (jpmorgan.com)

https://www.jpmorgan.com/country/US/EN/detail/1320543220127

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US